Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Dividend Updates

 Dear Sir, This is to inform you that the shareholders of Shilpa Medicare Limited at their Annual General Meeting Held on 20th September, 2019 at 12:15 P.M. at registered office of the company being #12-6-214/A-1, Hyderabad Road, Raichur - 584135 have resolved to declare Final dividend of Re. 1/- (Re. One only) per equity shares of Re. 1/- (Re. One only) each. This is for your information and records.
21-09-2019
Bigul

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Meeting Updates

 We wish to inform you that the 32nd Annual General Meeting (AGM) of the Company was held today, i.e., on 20th September, 2019 at the Registered Office of the Company at #12-6-214/A-1, Shilpa House, Hyderabad Road, Raichur- 584 135 which commenced at 12:15 P.M. and concluded at 12:54 P.M. and the business mentioned in the Notice convening the AGM were transacted. In this regard, please find enclosed the following; 1. Outcome of 32nd Annual General Meeting Under Regulation 30 SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure-I 2. Proceedings of AGM in compliance with the provisions of regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - II. This is for your information and record.
21-09-2019
Bigul

SHILPA MEDICARE LTD. - 530549 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 We wish to inform you that the 32nd Annual General Meeting (AGM) of the Company was held today, i.e., on 20th September, 2019 at the Registered Office of the Company at #12-6-214/A-1, Shilpa House, Hyderabad Road, Raichur- 584 135 which commenced at 12:15 P.M. and concluded at 12:54 P.M. and the business mentioned in the Notice convening the AGM were transacted. In this regard, please find enclosed the following; 1. Outcome of 32nd Annual General Meeting Under Regulation 30 SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure-I 2. Proceedings of AGM in compliance with the provisions of regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - II. This is for your information and record.
21-09-2019
Bigul

Shilpa Medicare Ltd - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepak Kumar Inani
18-09-2019
Bigul

Shilpa Medicare Ltd - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Brijgopal Inani & Omprakash Inani
17-09-2019
Bigul

Shilpa Medicare Ltd - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ramakant Inani
17-09-2019
Bigul

Shilpa Medicare Ltd - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepak Kumar Inani
17-09-2019
Bigul

Shilpa Medicare Ltd - 530549 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
17-09-2019
Bigul

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Meeting Updates

 With reference to the captioned subject, please be noted that at the meeting of the Board of Directors held today, i.e. on 10th September, 2019, Mr. Vakkalanka Venkata Krishna Chaitanya, who is a member of the Institute of Company Secretaries of India (ICSI), was appointed as the Company Secretary and Compliance officer of the Company w.e.f. 10th September, 2019.The details of the appointee are in Annexure-1. It is further intimated that meeting commenced at 12:05 P.M. and ended at 12:30 P.M.
10-09-2019
Bigul

SHILPA MEDICARE LTD. - 530549 - Intimation U/R 30 Of The SEBI(LODR) Regulations - Reg

 We hereby inform that the USFDA inspected the Company's Finished Dosage Formulation Facility (Sterile and Non-sterile Dosage Forms) located at S-20 to S-26, Pharmaceutical Formulations SEZ, APIIC, Jadcherla (Telangana State) from 29th August to 6th September, 2019. The inspection concluded with two (2) observations. There were no repeat observations or Data Integrity (DI) related observations. The company is confidence of addressing these observations and responding to the USFDA at the earliest. This is for your information and doing the needful
07-09-2019
Next Page
Close

Let's Open Free Demat Account